Mosaic Biosciences’ Post

How to create a long-term, high-value biopharmaceutical company in today’s landscape?   It all starts at the very beginning, as emphasized last week Rachel Mears, Partner at JEITO, in a BioCentury Inc. - Oppenheimer & Co. Inc. webinar dedicated to this crucial topic.    “𝘊𝘰𝘮𝘱𝘢𝘯𝘪𝘦𝘴 𝘤𝘢𝘯’𝘵 𝘫𝘶𝘴𝘵 𝘵𝘩𝘪𝘯𝘬 𝘢𝘣𝘰𝘶𝘵 𝘵𝘩𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦. 𝘐 𝘵𝘩𝘪𝘯𝘬 𝘭𝘦𝘢𝘥𝘦𝘳𝘴 𝘩𝘢𝘷𝘦 𝘵𝘰 𝘵𝘩𝘪𝘯𝘬 𝘢𝘣𝘰𝘶𝘵 𝘵𝘩𝘦 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘵𝘩𝘢𝘵 𝘵𝘩𝘦𝘺 𝘪𝘯𝘵𝘦𝘯𝘥 𝘵𝘰 𝘵𝘳𝘦𝘢𝘵 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘵𝘪𝘮𝘦 𝘪𝘵 𝘮𝘪𝘨𝘩𝘵 𝘵𝘢𝘬𝘦 𝘵𝘩𝘦𝘮 𝘵𝘰 𝘨𝘦𝘵 𝘵𝘰 𝘵𝘩𝘢𝘵 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘧𝘳𝘰𝘮 𝘥𝘢𝘺 𝘰𝘯𝘦”.   Much of the success will also depend on the leadership team's ability to navigate through all stages of development, she added.   “𝘐𝘵 𝘸𝘪𝘭𝘭 𝘳𝘦𝘲𝘶𝘪𝘳𝘦 𝘵𝘪𝘮𝘦 (…) 𝘠𝘰𝘶 𝘯𝘦𝘦𝘥 𝘢 𝘵𝘦𝘢𝘮 𝘵𝘩𝘢𝘵 𝘩𝘢𝘴 𝘢 𝘷𝘪𝘴𝘪𝘰𝘯 𝘵𝘩𝘢𝘵 𝘤𝘢𝘯 𝘴𝘵𝘳𝘢𝘥𝘥𝘭𝘦 𝘵𝘩𝘢𝘵 𝘵𝘪𝘮𝘦.”   Watch the replay of this webinar moderated by Simone Fishburn to discover the valuable insights of all panelists including Jami Rubin, Disith Patel, Michael Margolis and Joep Muijrers 👉 https://lnkd.in/e2vNy4tA   #biopharma #growth #innovation #leadership #patient

AeroSafe Global Raises $43M Funding to Transform Biopharmaceutical Cold Chain Solutions AeroSafe Global, a biopharmaceutical cold chain solutions provider, has successfully concluded a $43 million funding round. Spearheaded by NewSpring through its healthcare fund, NewSpring Health Capital, this funding marks a pivotal moment in AeroSafe’s journey toward revolutionizing the safety and sustainability of pharmaceutical deliveries. Distinguished healthcare investors, including Peloton Equity and Merck Global Health Innovation […] The post AeroSafe Global Raises $43M Funding to Transform Biopharmaceutical Cold Chain Solutions first appeared on USTechTimes - Leading Startup and Technology News in the United States . The post AeroSafe Global Raises $43M Funding to Transform Biopharmaceutical Cold Chain Solutions appeared first on USTechTimes - Leading Startup and Technology News in the United States . https://lnkd.in/gENWZTe9 #USTech #Tech

We're thrilled to announce that our President and CEO, Lars Petersen, will be a distinguished speaker on a panel at the Biomanufacturing World Summit in San Diego! 📅 Save the Date: November 15, 2023 at 1:55PM 🌐 Panel Topic will cover "CDMOs as Critical Partners in the Biopharmaceutical Ecosystem: Challenges and Trends in the Past, Present, and Future." Lars Petersen will delve into the transformation of Contract Development and Manufacturing Organizations (CDMOs) from service providers to indispensable partners in the biopharmaceutical ecosystem. Join us as he analyzes the challenges faced in meeting the rising demand for biopharmaceutical products and explores strategies employed to overcome capacity limitations. Key Discussion Points will be: - Importance of collaborative partnerships for innovation and accelerated drug development. - Technical challenges in bioprocessing: scalability, process optimization, and future technology convergence. - Role of CDMOs in supporting the development and manufacturing of complex personalized medicine (C>). - Forecasting future trends and identifying emerging opportunities in the CDMO industry. Don't miss this insightful discussion! Stay tuned for updates from the Biomanufacturing World Summit and gain valuable insights into the evolving landscape of the biopharmaceutical industry. #Biomanufacturing #CDMO #BWS2023 #BiopharmaInnovation #DrugDevelopment

Exciting Insights from BioPhorum’s Latest Presentation! 🌟 Join us for a deep dive into the world of Cell Line Development (CLD) with BioPhorum’s presentation, “When will we have a clone?” #bpiwest today! The session will be led by industry experts Stephanie Rieder from AbbVie and Ren Liu from Merck & Co., Inc., this session offers a comprehensive look at the typical CLD timeline. Thank you both! A heartfelt thank you to the brilliant contributing authors of this presentation. Their expertise and dedication have enriched our understanding of this critical field. Follow our page for updates on the upcoming publication! Let’s acknowledge and appreciate: 🌟 Howard Clarke from Seagen 🌟 Anke Mayer-Bartschmid representing Bayer 🌟 Chenxing Zheng of Incyte 🌟 Elizabeth Masterjohn from Sanofi 🌟 Falguni Patel at AbbVie 🌟 Mark Moffat from Pfizer 🌟 Qingxiang Wei at Incyte 🌟 Ren Liu from Merck & Co., Inc. 🌟 Robyn Emmins at GSK 🌟 Simon Fischer from Boehringer Ingelheim 🌟 Stephanie Rieder at AbbVie 🌟 Tom Kelly representing The Janssen Pharmaceutical Companies of Johnson & Johnson🌟 and lastly BioPhorum's own Emma Mason for her first class facilitation of the team. 🔬 Discover the stages of CLD, from pre-transfection to lead clone selection, and learn about the acceleration opportunities that can streamline the process. With insights from 27 companies, this presentation is a must-see for anyone in the biopharmaceutical field. 🤝 BioPhorum is all about collaboration and progress. Don’t miss out on this opportunity to connect with leaders and experts who are shaping the future of biopharma. If you are interested in finding out more about this upcoming publication or how to join please reach out to Tiffany Connor or Trish Connolly #BioPhorum #CellLineDevelopment #Biopharma #Innovation #Collaboration

The global biopharmaceutical supply chain is increasingly complex and volatile. Here are 6 trends we saw from the recent #CPHI conference in Barcelona: https://lnkd.in/eZA5k7Y2 #biopharma #supplychain

The global biopharmaceutical supply chain is increasingly complex and volatile. Here are 6 trends we saw from the recent #CPHI conference in Barcelona: https://lnkd.in/gkyZmuGa #biopharma #supplychain

The biopharmaceutical chain has been pushed to new limits in recent years. Here we report on the recent #CPHI conference in Barcelona and set out our perspective on the top trends and their leadership implications. #pharma #leadership #supplychain

The global biopharmaceutical supply chain is increasingly complex and volatile. Here are 6 trends we saw from the recent #CPHI conference in Barcelona: https://lnkd.in/gj2W4crr #biopharma #supplychain

🧬 Ascendis Pharma: Revolutionizing Biopharmaceuticals 🧬 From Denmark's vibrant bio-landscape emerges Ascendis Pharma. Harnessing the power of TransCon technologies, they're pushing boundaries and setting new paradigms in the biopharmaceutical industry. 🔍 Innovative TransCon Platform. 🌐 Integrated, patient-centric solutions. 🔬 Passionate about R&D. Discover the remarkable strides Ascendis Pharma is making in the world of biopharmaceuticals! #BioTech #HealthInnovation #DenmarkInnovation #Therapeutics #NordicTech 🧪 Link in the comments!

The global biopharmaceutical supply chain is increasingly complex and volatile. Here are 6 trends we saw from the recent #CPHI conference in Barcelona: https://lnkd.in/eSXY2GCa #biopharma #supplychain